May 8, 2019 12:28 PM EDT
Pharma

List prices in drug ads on TV com­ing as CMS fi­nal­izes rule

Zachary Brennan

Senior Editor

De­spite nu­mer­ous com­ments rais­ing ques­tions about a pro­pos­al to in­clude list prices in phar­ma­ceu­ti­cal di­rect-to-con­sumer (DTC) ad­ver­tise­ments, the Cen­ters for Medicare and Med­ic­aid Ser­vices …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

As the XBI suf­fers, Q1 shows a few com­fort­ing signs of un­der­ly­ing sta­bil­i­ty

Up­dat­ed: Roche’s $50B US in­vest­ment in­cludes pre­vi­ous build an­nounce­ments

Makary, in one of first com­ments on FDA pol­i­cy, floats new path­way for rare dis­ease drugs

As­traZeneca, Dai­ichi eye first-line breast can­cer mar­ket af­ter En­her­tu's ear­ly Phase 3 win

Drug­mak­ers stock­pile in­ven­to­ry in the US, seek­ing to get ahead of Trump tar­iffs

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times